Physician

Camille Johnson, M.D.

According to 2025 Medicare claims, Camille Johnson, M.D. (NPI: 1457732711) practices hematology/oncology in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Denton, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 76201-4315.

Johnson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 533 traditional Medicare patients, billed 147,504 HCPCS/CPT codes, and received $1,951,079 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 920 prescription claims across 176 beneficiaries totaling $1,132,631 in drug costs, led by Imbruvica (Ibrutinib). Open Payments data shows 38 records totaling $1,657. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.0M2022 Medicare payment: $151,525 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,007,436 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,951,079 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20228810,979$151,525
2023518152,793$2,007,436
2024533147,504$1,951,079

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$566K$1.1M2021 Drug cost: $2,554 (USD; Tot_Drug_Cst)2022 Drug cost: $20,957 (USD; Tot_Drug_Cst)2023 Drug cost: $725,770 (USD; Tot_Drug_Cst)2024 Drug cost: $1,132,631 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20211763$2,554
20223654$20,957
2023136618$725,770
2024176920$1,132,631

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more145285$92
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less104180$46
80053Blood test, comprehensive group of blood chemicals151406$10
36415Insertion of needle into vein for collection of blood sample161417$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count154404$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib21608$234,133
IbrancePalbociclib11308$176,694
EliquisApixaban391,443$26,931
XareltoRivaroxaban20840$15,184
ExemestaneExemestane402,560$5,544

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.38$1,657Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Camille Johnson, M.D.?

Tedicare shows public-source Medicare data for Camille Johnson, M.D. (NPI 1457732711), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Camille Johnson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Camille Johnson, M.D.?

Camille Johnson, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Camille Johnson, M.D. have Open Payments data?

Camille Johnson, M.D. has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.